Adjuvant Partners

Adjuvant Partners is the only life sciences business development and strategic consulting practice specializing in support for advanced therapies and regenerative medicine companies and organizations. These disciplines include but are not limited to: cell therapy, gene therapy, tissue engineering, immunotherapy, biomaterials and stem cells used for a variety of therapeutic and drug discovery applications. Our knowledge and expertise in this sector is unparalleled, and allows us to quickly evaluate partnering opportunities and recommend business development strategies to achieve optimum results for our clients. We also maintain the most comprehensive network of key contacts in the sector including large pharma executives, C-level execs at biotech companies with programs in regenerative medicine, investors, philanthropists, academic researchers, regulatory experts, and clinicians specializing in the field. Our client base is global, and extends across North America into Europe, Israel and parts of the Asia Pacific region.

Adjuvant's corporate offices in Washington D.C. provide immediate access to key decision makers on regulatory and reimbursement issues, as well as leading experts in the research establishment at NIH, the Department of Defense, the VA and other key federal agencies. We also maintain offices in San Diego, New York, Minneapolis and Tel Aviv. For our clients outside the U.S., we help guide them through the entire business development process, including providing regulatory strategy and a clinical and commercial framework that will resonate with prospective partners.

It is our firm conviction that many of the advanced therapy and regenerative medicine technologies being developed by our clients will transform medicine. Adjuvant Partners will be the catalyst to make this happen.

      Privacy Policy

© Adjuvant Partners, LLC 2013. All rights reserved.